3rd Quarter - Report

PODESTA GROUP, INC. for GENZYME

Firm
Client
Income
$200,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions Comparative Effectiveness Lab demonstration issue H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 H.R. 1424, Emergency Economic Stabilization Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008 ESRD "bundling issues" and ESRD drug reimbursement issues MIPPA Technical Corrections

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
SHARON COHEN —
RANDALL GERARD —
ELIZABETH ANN MORRA 1995-2001 House Appropriations Committee
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson
WALTER PRYOR U.S. Senator David Pryor
THOMAS B SPARKMAN New Health Policy Intern, Senate HELP Committee

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ)

Bills named: H.R. 3162 (110th), S. 3101 (110th), H.R. 6331 (110th), H.R. 4 (110th), S. 1376 (110th), H.R. 2606 (110th), H.R. 5480 (110th), S. 2662 (110th), S. 3 (110th), S. 2029 (110th), H.R. 1424 (110th)

Budget/Appropriations BUD

House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution LHHS Appropriations Comparative Effectiveness H.R. 2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009

LobbyistCovered position, as disclosed
SHARON COHEN —
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ELIZABETH ANN MORRA —
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson
THOMAS B SPARKMAN New Health Policy Intern, Senate HELP Committee

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA)

Bills named: H.R. 2638 (110th)

Pharmacy PHA

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Neglected Disease Issues

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson
THOMAS B SPARKMAN New Health Policy Intern, Senate HELP Committee

Contacted: Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 596 (110th), H.R. 1956 (110th), S. 2029 (110th), S. 1695 (110th), S. 4 (110th), S. 1505 (110th), H.R. 1038 (110th), S. 623 (110th), H.R. 5629 (110th)

Taxation/Internal Revenue Code TAX

Neglected Disease Tax Credit H.R. 1424, Emergency Economic Stabilization Act of 2008

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
DAVID MARIN Leg Dir & Press Sec'y, Rep. Tom Davis
ANNE MARIE POLAK Leg. Correspondent for Cong. Mike Ferguson
LANTIE SLENZAK Legislative Director, Rep. Gene Green
THOMAS B SPARKMAN New Health Policy Intern, Senate HELP Committee
MICHELLE TESSIER —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1424 (110th)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007 S. 3600, Patent Reform Act of 2008 H R. 1908, Patent Reform Act of 2007

LobbyistCovered position, as disclosed
SHARON COHEN —
COURTNEY HAGEN —
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson
LANTIE SLENZAK Leg. Dir. Rep. Gene Green
THOMAS B SPARKMAN New Health Policy Intern, Senate HELP Committee

Contacted: Health & Human Services, Dept of (HHS); SENATE; Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 3600 (110th), S. 1145 (110th), H.R. 1908 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.